Career Enhancement Program

职业提升计划概要/摘要 职业提升计划（CEP）的目标是培养训练有素，卓越的新员工。 研究人员致力于转化研究的早期发现，预防和治疗 子宫内膜癌这些调查人员和他们的研究将最终有助于降低发病率， 这种疾病的死亡率。CEP将1）招募和培训医生和基础科学家，使他们能够 成为子宫内膜癌领域的高技能翻译研究人员; 2）提供具体的 子宫内膜癌研究的知识，这将提高获奖者进行创新的能力， 将直接影响对这种疾病的理解和治疗的转化科学; 3）重新指导 这些人已经在子宫内膜癌研究中表现出相当大的科学前景。到 为了实现这一目标，SPORE CEP将每年提供至少两个50，000美元的奖项，为期两年， 由SPORE和/或MD安德森的匹配基金或慈善基金资助。我们将积极 招募最有前途的新研究者，并制定个性化的发展计划， 实验室导师和指导委员会，指导赠款和手稿写作，领导力培训， 与子宫内膜癌学者建立联系，完成并发表翻译的子宫内膜癌 同行评审期刊上的手稿。CEP将鼓励和支持获奖者在国家 会议. CEP将由医学博士戴安娜·博杜卡领导，MD的医学教育副总裁 安德森和妇科肿瘤学家，以及医学博士大卫格申森，前外交部主席 MD安德森妇科肿瘤学。罗素布罗德斯，医学博士，哲学博士、SPORE Co-PI将提供监督 因为SPORE领导层认识到了该计划的重要性。九位前CEP获奖者 在当前的SPORE竞争性更新中发挥着重要作用，无论是作为项目的共同调查员， 领先的临床试验，为研究项目的发展提供重要的初步数据，或 在SPORE外部顾问委员会任职。

Career Enhancement Program SUMMARY/ABSTRACT The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional new investigators dedicated to translational research in the early detection, prevention, and treatment of endometrial cancer. These investigators and their research will ultimately help to reduce the morbidity and mortality from this disease. The CEP will 1) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of endometrial cancer; 2) provide specific knowledge of research in endometrial cancer that will enhance the ability of awardees to conduct innovative translational science that will directly impact the understanding and treatment of this disease; and 3) re-direct individuals who have already shown considerable scientific promise into endometrial cancer research. To achieve this goal, the SPORE CEP will provide at least two awards of $50,000 annually for up to two years, funded from the SPORE and/or matching funds or philanthropic funds from MD Anderson. We will aggressively recruit the most promising new investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee, coaching in grant and manuscript writing, leadership training, networking with endometrial cancer scholars, and completing and publishing a translational endometrial cancer manuscript in a peer-reviewed journal. The CEP will encourage and support awardee presentations at national meetings. The CEP will be led by Diana Bodurka, M.D., the Vice President of Medical Education at MD Anderson and a gynecologic oncologist, and David Gershenson, M.D., the former Chair of the Department of Gynecologic Oncology at MD Anderson. Russell Broaddus, M.D., Ph.D., SPORE Co-PI, will provide oversight to the CEP, as SPORE leadership recognizes the importance of this program. Nine previous CEP awardees are playing major roles in the current SPORE competitive renewal, either as co-investigators on projects, leading clinical trials, contributing important preliminary data for the development of a research project, or serving on the SPORE External Advisory Board.